早期达托霉素治疗对万古霉素最低抑菌浓度较高的耐甲氧西林金黄色葡萄球菌菌血症治疗结局的影响。 - Suppr

Influence of early daptomycin therapy on treatment outcome of meticillin-resistant Staphylococcus aureus bacteraemia with high vancomycin minimum inhibitory concentrations.

作者信息

Cheng Chun-Wen, Hsu Po-Chang, Yang Chien-Chang, Chang Hong-Jyun, Siu Leung-Kei, Wu Tsu-Lan, Huang Ching-Tai, Lee Ming-Hsun

出版信息

Int J Antimicrob Agents. 2013 Mar;41(3):293-4. doi: 10.1016/j.ijantimicag.2012.10.019. Epub 2013 Jan 9.

DOI:10.1016/j.ijantimicag.2012.10.019

PMID:23312599

Abstract

摘要

相似文献

Influence of early daptomycin therapy on treatment outcome of meticillin-resistant Staphylococcus aureus bacteraemia with high vancomycin minimum inhibitory concentrations.早期达托霉素治疗对万古霉素最低抑菌浓度较高的耐甲氧西林金黄色葡萄球菌菌血症治疗结局的影响。

Int J Antimicrob Agents. 2013 Mar;41(3):293-4. doi: 10.1016/j.ijantimicag.2012.10.019. Epub 2013 Jan 9.

Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.达托霉素与万古霉素治疗耐甲氧西林金黄色葡萄球菌血流感染合并高万古霉素最低抑菌浓度：一项病例对照研究。

Clin Infect Dis. 2012 Jan 1;54(1):51-8. doi: 10.1093/cid/cir764. Epub 2011 Nov 21.

Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.早期使用达托霉素与万古霉素治疗万古霉素最低抑菌浓度（MIC）＞1mg/L 的耐甲氧西林金黄色葡萄球菌菌血症：一项匹配队列研究。

Clin Infect Dis. 2013 Jun;56(11):1562-9. doi: 10.1093/cid/cit112. Epub 2013 Feb 28.

High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.高万古霉素最低抑菌浓度是耐甲氧西林金黄色葡萄球菌菌血症患者死亡的预测因素。

Int J Antimicrob Agents. 2012 Aug;40(2):108-13. doi: 10.1016/j.ijantimicag.2012.04.003. Epub 2012 May 26.

Fatal bacteraemia caused by daptomycin-non-susceptible, vancomycin-intermediate, meticillin-resistant Staphylococcus aureus in a patient with chronic kidney disease.一名慢性肾脏病患者发生由对达托霉素不敏感、万古霉素中介、耐甲氧西林金黄色葡萄球菌引起的致死性菌血症。

Int J Antimicrob Agents. 2009 Jan;33(1):96-8. doi: 10.1016/j.ijantimicag.2008.06.028. Epub 2008 Sep 13.

Is high vancomycin minimum inhibitory concentration a good marker to predict the outcome of methicillin-resistant Staphylococcus aureus bacteremia?高万古霉素最低抑菌浓度是预测耐甲氧西林金黄色葡萄球菌菌血症预后的良好指标吗？

J Infect Dis. 2010 Jan 15;201(2):311-2; author reply 312-3. doi: 10.1086/649572.

A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.一项关于万古霉素与达托霉素治疗万古霉素最低抑菌浓度较高的耐甲氧西林金黄色葡萄球菌菌血症的随机2B期试验——一项提前终止研究的结果

Trials. 2018 Jun 1;19(1):305. doi: 10.1186/s13063-018-2702-8.

Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia.一名患有耐甲氧西林金黄色葡萄球菌菌血症的青少年使用达托霉素治疗失败。

Pediatr Infect Dis J. 2009 May;28(5):445-7. doi: 10.1097/INF.0b013e3181927891.

Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy.回顾性病例对照分析接受达托霉素或糖肽类药物治疗的葡萄球菌感染患者。

Int J Antimicrob Agents. 2012 Jan;39(1):64-8. doi: 10.1016/j.ijantimicag.2011.09.011. Epub 2011 Nov 1.

Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.利福平联合达托霉素治疗达托霉素中介耐甲氧西林金黄色葡萄球菌菌血症

Ann Pharmacother. 2010 May;44(5):918-21. doi: 10.1345/aph.1M665. Epub 2010 Mar 30.

引用本文的文献

Comparative effectiveness of daptomycin versus vancomycin among patients with methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: A systematic literature review and meta-analysis.比较耐甲氧西林金黄色葡萄球菌（MRSA）血流感染患者使用达托霉素与万古霉素的疗效：系统文献回顾和荟萃分析。

PLoS One. 2024 Feb 21;19(2):e0293423. doi: 10.1371/journal.pone.0293423. eCollection 2024.

New advances in management and treatment of cardiac implantable electronic devices infections.心脏植入式电子设备感染的管理和治疗新进展。

Infection. 2024 Apr;52(2):323-336. doi: 10.1007/s15010-023-02130-8. Epub 2023 Nov 24.

Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis.达托霉素与万古霉素治疗万古霉素最低抑菌浓度>1µg/mL的耐甲氧西林金黄色葡萄球菌引起的菌血症的疗效和安全性：一项系统评价和荟萃分析。

Pharmaceutics. 2022 Mar 27;14(4):714. doi: 10.3390/pharmaceutics14040714.

Trials. 2018 Jun 1;19(1):305. doi: 10.1186/s13063-018-2702-8.

Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European Cubicin(®) Outcomes Registry and Experience.大剂量达托霉素的有效性和安全性评估：欧洲 Cubicin（®）结果登记处纳入患者的结果与经验

Adv Ther. 2015 Dec;32(12):1192-205. doi: 10.1007/s12325-015-0267-4. Epub 2015 Nov 26.

Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) Registry.临床环境中的达托霉素：来自欧盟核心（SM）注册研究的8年革兰氏阳性菌感染经验。

Adv Ther. 2015 Jun;32(6):496-509. doi: 10.1007/s12325-015-0220-6. Epub 2015 Jun 25.

Clinical management of Staphylococcus aureus bacteremia: a review.金黄色葡萄球菌菌血症的临床管理：综述。

JAMA. 2014 Oct 1;312(13):1330-41. doi: 10.1001/jama.2014.9743.

Vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: study protocol for a phase IIB randomized controlled trial.万古霉素与达托霉素治疗万古霉素最低抑菌浓度较高的耐甲氧西林金黄色葡萄球菌菌血症：一项IIB期随机对照试验的研究方案

Trials. 2014 Jun 19;15:233. doi: 10.1186/1745-6215-15-233.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Influence of early daptomycin therapy on treatment outcome of meticillin-resistant Staphylococcus aureus bacteraemia with high vancomycin minimum inhibitory concentrations.

作者信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献